Non-mental health inpatient and emergency care hospital costs associated with four mental disorders in Europe: a modelling study.
Wienand D. et al, (2025), The lancet. Psychiatry, 12, 513 - 523
A single dose of lamotrigine induces a positive memory bias in healthy volunteers.
Zghoul T. et al, (2025), Psychol Med, 55
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
Goodwin GM. et al, (2025), J Clin Psychiatry, 86
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Goodwin GM. et al, (2025), J Affect Disord, 372, 523 - 532
Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.
Kirlić N. et al, (2025), Am J Psychiatry, 182, 126 - 132
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.
Marwood L. et al, (2024), J Psychiatr Res, 180, 198 - 203
Exploring the incidence of inadequate response to antidepressants in the primary care of depression.
Abrahams AB. et al, (2024), Eur Neuropsychopharmacol, 83, 61 - 70
Hypersexuality in bipolar disorder: an overlooked symptom.
Dolman C. et al, (2024), Lancet Psychiatry, 11, 405 - 406
Comorbid physical health burden of serious mental health disorders in 32 European countries.
Wienand D. et al, (2024), BMJ Ment Health, 27
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
E-Wen McCulloch D. et al, (2024), Neuroscience Applied, 3
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
Pasculli G. et al, (2024), Front Hum Neurosci, 18
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.
Goodwin GM. et al, (2024), Am J Psychiatry, 181, 79 - 81
A single dose of lamotrigine induces a positive memory bias in healthy volunteers
Zghoul T. et al, (2023)
Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial.
Landrø NI. et al, (2023), Contemporary clinical trials, 133, 107326 - 107326
The psychedelic experience and treatment-resistant depression.
Goodwin GM., (2023), World Psychiatry, 22, 420 - 422
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
Dougherty RF. et al, (2023), Psychopharmacology (Berl)
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder.
Steel C. et al, (2023), Int J Bipolar Disord, 11
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Goodwin GM. et al, (2023), Neuropsychopharmacology